Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2976
Olema Pharmaceuticals
OLMA
$930M
| $9.81M | ﹤0.01% |
1,683,207
+430,462
| +34% | +$4.3M |
|
2977
PUT
Incyte
INCY
$24.4B
| $9.81M | ﹤0.01% |
142,000
-500
| -0.4% | -$35.6K |
|
|
BPMC
2978
PUT
DELISTED
Blueprint Medicines
BPMC
| $9.8M | ﹤0.01% |
112,400
+24,500
| +28% | +$2.24M |
|
2979
PUT
Aecom
ACM
$8.12B
| $9.8M | ﹤0.01% |
91,700
+7,500
| +9% | +$819K |
|
2980
CALL
Lumen
LUMN
$6.93B
| $9.79M | ﹤0.01% |
1,843,800
-3,511,700
| -66% | -$24.2M |
|
2981
CALL
TG Therapeutics
TGTX
$7.46B
| $9.78M | ﹤0.01% |
324,900
-1,800
| -0.6% | -$51.7K |
|
2982
RUM Group Inc
RUM
$3.7B
| $9.75M | ﹤0.01% |
749,505
+747,714
| +41,748% | +$5.32M |
|
2983
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.41B
| $9.75M | ﹤0.01% |
363,429
+277,377
| +322% | +$8.68M |
|
2984
Perdoceo Education
PRDO
$2B
| $9.75M | ﹤0.01% |
368,367
+166,297
| +82% | +$4.09M |
|
2985
Zentalis Pharmaceuticals
ZNTL
$255M
| $9.75M | ﹤0.01% |
3,216,727
+499,206
| +18% | +$1.64M |
|
2986
ARK Innovation ETF
ARKK
$6.42B
| $9.74M | ﹤0.01% |
171,650
+107,449
| +167% | +$5.76M |
|
2987
Sportradar
SRAD
$4.09B
| $9.74M | ﹤0.01% |
561,446
-178,307
| -24% | -$2.69M |
|
2988
PUT
Fidelity Wise Origin Bitcoin Fund
FBTC
$11.7B
| $9.73M | ﹤0.01% |
+119,300
| New | +$8.65M |
|
2989
Newell Brands
NWL
$2.66B
| $9.73M | ﹤0.01% |
977,021
-3,833,125
| -80% | -$34.8M |
|
2990
PUT
Douglas Emmett
DEI
$1.96B
| $9.72M | ﹤0.01% |
523,800
+179,900
| +52% | +$3.35M |
|
2991
Inspire Medical Systems
INSP
$1.65B
| $9.72M | ﹤0.01% |
52,421
-57,890
| -52% | -$11.2M |
|
|
MRX
2992
Marex Group Limited Ordinary Shares
MRX
$5.11B
| $9.71M | ﹤0.01% |
311,582
-181,574
| -37% | -$5.08M |
|
2993
Masco
MAS
$14.7B
| $9.71M | ﹤0.01% |
133,781
+125,967
| +1,612% | +$10.1M |
|
2994
PUT
Northern Trust
NTRS
$35B
| $9.71M | ﹤0.01% |
94,700
-9,600
| -9% | -$981K |
|
2995
CALL
Tidewater
TDW
$4.69B
| $9.7M | ﹤0.01% |
177,300
+52,300
| +42% | +$2.98M |
|
|
ECG
2996
Everus Construction Group
ECG
$7.2B
| $9.7M | ﹤0.01% |
+147,490
| New | +$9.28M |
|
2997
Aon
AON
$75.5B
| $9.7M | ﹤0.01% |
27,000
-127,891
| -83% | -$47M |
|
|
NVMI
2998
Nova
NVMI
$13.3B
| $9.7M | ﹤0.01% |
49,234
+40,721
| +478% | +$7.83M |
|
2999
PUT
Copa Holdings
CPA
$6.14B
| $9.68M | ﹤0.01% |
110,200
+61,800
| +128% | +$5.86M |
|
3000
Autohome
ATHM
$2.61B
| $9.68M | ﹤0.01% |
373,007
-16,302
| -4% | -$470K |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.